ArticleVaccine2016
Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV.
Ethan Poteet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it